These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 38508558)

  • 1. Regulation of lipid metabolism by E3 ubiquitin ligases in lipid-associated metabolic diseases.
    Zou Y; Zhang Y; Li M; Cao K; Song C; Zhang Z; Cai K; Geng D; Chen S; Wu Y; Zhang N; Sun G; Wang J; Zhang Y; Sun Y
    Int J Biol Macromol; 2024 Apr; 265(Pt 2):130961. PubMed ID: 38508558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting E3 ubiquitin ligases and their adaptors as a therapeutic strategy for metabolic diseases.
    Jeong Y; Oh AR; Jung YH; Gi H; Kim YU; Kim K
    Exp Mol Med; 2023 Oct; 55(10):2097-2104. PubMed ID: 37779139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted modulation of E3 ligases using engineered ubiquitin variants.
    LeBlanc N; Mallette E; Zhang W
    FEBS J; 2021 Apr; 288(7):2143-2165. PubMed ID: 32867007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver cytochrome P450 3A ubiquitination in vivo by gp78/autocrine motility factor receptor and C terminus of Hsp70-interacting protein (CHIP) E3 ubiquitin ligases: physiological and pharmacological relevance.
    Kim SM; Acharya P; Engel JC; Correia MA
    J Biol Chem; 2010 Nov; 285(46):35866-77. PubMed ID: 20819951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. E3-ubiquitin ligases and recent progress in osteoimmunology.
    Asano Y; Matsumoto Y; Wada J; Rottapel R
    Front Immunol; 2023; 14():1120710. PubMed ID: 36911671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulating the Regulators: Recent Revelations in the Control of E3 Ubiquitin Ligases.
    Vittal V; Stewart MD; Brzovic PS; Klevit RE
    J Biol Chem; 2015 Aug; 290(35):21244-51. PubMed ID: 26187467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The exploitation of host autophagy and ubiquitin machinery by
    Shariq M; Quadir N; Alam A; Zarin S; Sheikh JA; Sharma N; Samal J; Ahmad U; Kumari I; Hasnain SE; Ehtesham NZ
    Autophagy; 2023 Jan; 19(1):3-23. PubMed ID: 35000542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The E3 ubiquitin ligases, HUWE1 and NEDD4-1, are involved in the post-translational regulation of the ABCG1 and ABCG4 lipid transporters.
    Aleidi SM; Howe V; Sharpe LJ; Yang A; Rao G; Brown AJ; Gelissen IC
    J Biol Chem; 2015 Oct; 290(40):24604-13. PubMed ID: 26296893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RING-Between-RING E3 Ligases: Emerging Themes amid the Variations.
    Dove KK; Klevit RE
    J Mol Biol; 2017 Nov; 429(22):3363-3375. PubMed ID: 28827147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activity-based E3 ligase profiling uncovers an E3 ligase with esterification activity.
    Pao KC; Wood NT; Knebel A; Rafie K; Stanley M; Mabbitt PD; Sundaramoorthy R; Hofmann K; van Aalten DMF; Virdee S
    Nature; 2018 Apr; 556(7701):381-385. PubMed ID: 29643511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. E3 Ubiquitin Ligases in Endothelial Dysfunction and Vascular Diseases: Roles and Potential Therapies.
    Wang Y; Zhan Y; Wang L; Huang X; Xin HB; Fu M; Qian Y
    J Cardiovasc Pharmacol; 2023 Aug; 82(2):93-103. PubMed ID: 37314134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessing the Direct Binding of Ark-Like E3 RING Ligases to Ubiquitin and Its Implication on Their Protein Interaction Network.
    Mintis DG; Chasapi A; Poulas K; Lagoumintzis G; Chasapis CT
    Molecules; 2020 Oct; 25(20):. PubMed ID: 33086510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. On the Possibility That Bond Strain Is the Mechanism of RING E3 Activation in the E2-Catalyzed Ubiquitination Reaction.
    Johnson JK; Sumner I
    J Chem Inf Model; 2022 Dec; 62(24):6475-6481. PubMed ID: 35671046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and Characterization of Physiological Pairing of E2 Ubiquitin-Conjugating Enzymes and E3 Ubiquitin Ligases.
    Brillada C; Trujillo M
    Methods Mol Biol; 2023; 2581():13-29. PubMed ID: 36413307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BioE3 identifies specific substrates of ubiquitin E3 ligases.
    Barroso-Gomila O; Merino-Cacho L; Muratore V; Perez C; Taibi V; Maspero E; Azkargorta M; Iloro I; Trulsson F; Vertegaal ACO; Mayor U; Elortza F; Polo S; Barrio R; Sutherland JD
    Nat Commun; 2023 Nov; 14(1):7656. PubMed ID: 37996419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of hepatic circadian metabolism by the E3 ubiquitin ligase HRD1-controlled CREBH/PPARα transcriptional program.
    Kim H; Wei J; Song Z; Mottillo E; Samavati L; Zhang R; Li L; Chen X; Jena BP; Lin JD; Fang D; Zhang K
    Mol Metab; 2021 Jul; 49():101192. PubMed ID: 33592335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The roles of E3 ubiquitin ligases in cancer progression and targeted therapy.
    Sampson C; Wang Q; Otkur W; Zhao H; Lu Y; Liu X; Piao HL
    Clin Transl Med; 2023 Mar; 13(3):e1204. PubMed ID: 36881608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ISG15 inhibits Nedd4 ubiquitin E3 activity and enhances the innate antiviral response.
    Malakhova OA; Zhang DE
    J Biol Chem; 2008 Apr; 283(14):8783-7. PubMed ID: 18287095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. E3 ubiquitin ligases and cerebral cortex development in health and disease.
    Lambert N; Moïse M; Nguyen L
    Dev Neurobiol; 2022 Jul; 82(5):392-407. PubMed ID: 35476229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of the Mitochondrial E3 Ubiquitin Ligases as Possible Therapeutic Targets in Cancer Therapy.
    Di Gregorio J; Appignani M; Flati V
    Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.